You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 17, 2025

Details for Patent: 11,014,965


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,014,965 protect, and when does it expire?

Patent 11,014,965 protects ZILBRYSQ and is included in one NDA.

This patent has eighty-eight patent family members in twenty-eight countries.

Summary for Patent: 11,014,965
Title:Modulation of complement activity
Abstract:The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.
Inventor(s):Michelle Denise Hoarty, Ketki Ashok Dhamnaskar, Daniel Elbaum, Kristopher Josephson, Kelley Cronin Larson, Zhong Ma, Nathan Ezekiel Nims, Alonso Ricardo, Kathleen Seyb, Guo-Qing Tang, Douglas A. Treco, Zhaolin Wang, Ping Ye, Hong Zheng, Sarah Jacqueline Perlmutter, Robert Paul Hammer
Assignee: Ucb Holdings Inc
Application Number:US16/732,502
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property law, providing inventors and companies with the exclusive rights to their inventions. The scope and claims of a patent are vital elements that define the boundaries of this exclusivity. This article will delve into the intricacies of patent scope and claims, using the example of US Patent 11,014,965, and provide a comprehensive analysis of the patent landscape in the United States.

What are Patent Claims?

Patent claims are the legal definitions of the invention that the patent covers. They are the most critical part of a patent application, as they determine the scope of protection granted to the inventor[5].

Importance of Claim Scope

The scope of patent claims is not just about breadth; it is about precision and relevance. A common misconception is that broader claims are better, but this is not always the case. Broader claims can be more difficult to get granted and are easier to invalidate. The claim scope must be anchored to the embodiments disclosed in the specification to avoid invalidation grounds such as the abstract idea exception and failure to meet the written description requirement[5].

Metrics for Measuring Patent Scope

Research has identified simple metrics to measure patent scope, including independent claim length and independent claim count. These metrics have explanatory power for several correlates of patent scope, such as patent maintenance payments, forward citations, and the breadth of patent classes. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

The Examination Process and Patent Scope

The patent examination process often narrows the scope of patent claims. This is evident in the changes observed in claim length and claim count during the examination process. Longer examination durations tend to result in more significant narrowing of the claims, ensuring that the granted patent is more focused and less likely to be overly broad[3].

Patent Eligibility and the Alice Test

The Supreme Court's "Alice" test is crucial in determining the patent eligibility of claims, particularly those directed to abstract ideas. The test involves two steps: first, determining if the claims are directed to an abstract idea, and second, assessing whether the claims recite something "significantly more" than the abstract idea itself. This test ensures that patents are granted for specific technological improvements rather than abstract concepts[2].

Industry Trends and Patenting Activity

Patenting activity is highly concentrated in knowledge- and technology-intensive industries. In the United States, high-technology manufacturing industries receive a significant share of patents. For example, in 2015, these industries received 61% of the patents granted to U.S. manufacturing industries. The Information and Communication Technology (ICT) category is particularly dominant, with computer technology, digital communication, semiconductors, and telecommunications being key areas[1].

Strategic Patenting

Companies often engage in strategic patenting to block competitors, negotiate with rivals, or build "thickets" of patents to impede others' R&D and innovation. New and emerging firms may seek patent protection to help obtain financing, as investors view patents as valuable assets for future profitability. International differences in taxes on corporate and patent income also influence the choice of patent location for multinational firms[1].

The Role of Small Claims Patent Courts

There is ongoing discussion about the need for a small claims patent court in the United States. Such a court would aim to provide a more accessible and cost-effective way for smaller entities to resolve patent disputes. The Administrative Conference of the United States (ACUS) has conducted studies and gathered public comments on the feasibility and structure of such a court, highlighting the legal, policy, and practical considerations involved[4].

Case Study: US Patent 11,014,965

While the specific details of US Patent 11,014,965 are not provided in the sources, we can apply the general principles discussed above to understand its scope and claims.

  • Claim Construction: The claims of the patent would need to be carefully constructed to avoid being overly broad and to ensure they meet the written description requirement. This involves ensuring that the claims are anchored to the specific embodiments disclosed in the specification.

  • Patent Eligibility: The claims would need to pass the "Alice" test to ensure they are directed to patent-eligible subject matter. This involves determining if the claims are directed to an abstract idea and whether they recite something "significantly more" than the abstract idea itself.

  • Industry Context: Understanding the industry in which the patent is filed is crucial. For instance, if the patent falls under the ICT category, it would be part of a highly competitive and technologically advanced field, where the scope of claims needs to be precisely defined to avoid infringement and invalidation issues.

  • Strategic Considerations: The patent holder may have strategic reasons for filing the patent, such as blocking competitors or obtaining financing. These considerations would influence the scope and claims of the patent.

Key Takeaways

  • Precision in Claims: The scope of patent claims must be precise and anchored to the embodiments disclosed in the specification.
  • Patent Eligibility: Claims must pass the "Alice" test to ensure they are directed to patent-eligible subject matter.
  • Industry Trends: Understanding the industry context is crucial for defining the scope of claims.
  • Strategic Patenting: Companies often engage in strategic patenting to achieve various business objectives.
  • Examination Process: The patent examination process tends to narrow the scope of claims, ensuring that granted patents are more focused.

FAQs

Q: What is the importance of claim scope in a patent application? A: The claim scope is critical as it defines the boundaries of the invention and determines the protection granted. Broader claims are not always better and can be more difficult to get granted and easier to invalidate.

Q: How does the "Alice" test impact patent claims? A: The "Alice" test ensures that patent claims are not directed to abstract ideas but rather to specific technological improvements. It involves a two-step process to determine patent eligibility.

Q: Why is strategic patenting important for companies? A: Strategic patenting allows companies to block competitors, negotiate with rivals, build patent "thickets," and obtain financing by demonstrating valuable intellectual property assets.

Q: What role could a small claims patent court play in the US patent system? A: A small claims patent court would provide a more accessible and cost-effective way for smaller entities to resolve patent disputes, addressing legal, policy, and practical considerations.

Q: How do industry trends influence patenting activity? A: Industry trends, particularly in knowledge- and technology-intensive sectors, significantly influence patenting activity. High-technology manufacturing and ICT categories are particularly dominant in patent filings.

Sources

  1. National Science Foundation. Science and Engineering Indicators 2018, Chapter 8 - Invention, Knowledge Transfer, and Innovation.
  2. United States Court of Appeals for the Federal Circuit. CONTOUR IP HOLDING LLC v. GOPRO, INC., 2024.
  3. SSRN. Patent Claims and Patent Scope, 2016.
  4. Administrative Conference of the United States. U.S. Patent Small Claims Court, 2022.
  5. Rimon Law. The Importance of Getting the Claim Scope Right in a US Patent Application, 2021.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,014,965

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ucb Inc ZILBRYSQ zilucoplan sodium SOLUTION;SUBCUTANEOUS 216834-001 Oct 17, 2023 RX Yes Yes 11,014,965 ⤷  Try for Free Y TREATMENT OF GENERALIZED MYASTHENIA GRAVIS (GMG) IN AN ADULT PATIENT WHO IS ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE BY SUBCUTANEOUS ADMINISTRATION OF C5 COMPLEMENT INHIBITOR ZILUCOPLAN ⤷  Try for Free
Ucb Inc ZILBRYSQ zilucoplan sodium SOLUTION;SUBCUTANEOUS 216834-002 Oct 17, 2023 RX Yes Yes 11,014,965 ⤷  Try for Free Y TREATMENT OF GENERALIZED MYASTHENIA GRAVIS (GMG) IN AN ADULT PATIENT WHO IS ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE BY SUBCUTANEOUS ADMINISTRATION OF C5 COMPLEMENT INHIBITOR ZILUCOPLAN ⤷  Try for Free
Ucb Inc ZILBRYSQ zilucoplan sodium SOLUTION;SUBCUTANEOUS 216834-003 Oct 17, 2023 RX Yes Yes 11,014,965 ⤷  Try for Free Y TREATMENT OF GENERALIZED MYASTHENIA GRAVIS (GMG) IN AN ADULT PATIENT WHO IS ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE BY SUBCUTANEOUS ADMINISTRATION OF C5 COMPLEMENT INHIBITOR ZILUCOPLAN ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,014,965

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3154561 ⤷  Try for Free CA 2024 00021 Denmark ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free 301275 Netherlands ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free PA2024514 Lithuania ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free LUC00343 Luxembourg ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free 2024C/518 Belgium ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free 17/2024 Austria ⤷  Try for Free
European Patent Office 3154561 ⤷  Try for Free 122024000028 Germany ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.